Evidence map›Paper›PMID 39973230›Full record

ReviewPediatric dermatology

Cosmeceuticals in the Pediatric Population Part II: Ethical Dilemmas and Patient Talking Points.

Gabrielle Keller Goff, Sarah L Stein

Abstract readReview
In one paragraph

Review in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Dermatologists' Perspectives on Skincare Routine Trends.Clinical, cosmetic and investigational dermatology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gabrielle Keller GoffPritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0008-8711-7880
Sarah L SteinDepartment of Medicine and Pediatrics, Section of Dermatology, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-0221-6844

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise in the use of cosmeceutical products amongst the pediatric population raises several ethical dilemmas, as well as new situations and questions that dermatologists must navigate with patients. Ethical concerns discussed in this review include the marketing of cosmeceutical products directly to children, the influence of social media and trends related to skincare, the use of anti-aging ingredients by children (who have not yet manifested any aging signs), and the misuse of cosmeceutical products to lighten one's complexion in childhood. We also discuss several related patient talking points for dermatologists to employ with young patients interested in cosmeceutical products.

Indexed as

CosmeceuticalsPediatricsChildDermatologyEthical DilemmasHumansPhysician-Patient RelationsSkin AgingSkin CareSocial MediaCosmeceuticalsacnechildrencosmeceuticalspediatricsskincare

Identifiers

PMID39973230
PMCPMC11950794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.